In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

Merck & Co.’s recent $1.3 billion deal to reel in Modifi Biosciences seemed to ignore pharma’s common dealmaking wisdom. It ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain cancer.

A spin-out from the University of Edinburgh in Scotland is already equipped with 15 million pounds ($19 million) in seed ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Press Release4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ...

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ImmunotherapyCompany founded by 4BIO Capital and ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...